ARTICLE | Company News

Access Pharmaceuticals, BioScrip sales and marketing update

September 27, 2010 7:00 AM UTC

Access launched its MuGard mucoadhesive oral rinse to treat and prevent oral mucositis (OM) in the U.S. The company said it received its first order of MuGard valued at more than $700,000 from its U....